The Nigerian Medical Association (NMA), Delta State Branch, has officially distance itself from and debunked the medical documents circulated by relationship coach Blessing Okoro, popularly known as Blessing CEO.
The controversy reached a boiling point today, Thursday, April 9, 2026, following allegations that the influencer faked a Stage 4 Breast Cancer diagnosis to solicit funds and sympathy from the public.
The “Forgery” Allegations
The backlash intensified after digital investigators and health advocates compared Blessing CEO’s posted “medical report” with an original document belonging to a makeup artist identified as Miss Mbara.
- The Original Owner: Reports indicate that Miss Mbara, a genuine cancer survivor from Asaba, had shared her diagnosis details with Blessing in confidence.
- The Alterations: Critics pointed out that the document Blessing shared appeared to be a digitally altered version of Miss Mbara’s report. Notable discrepancies included a name change and an attempt to swap the hospital’s location from Asaba, Delta State, to Enugu.
- NMA Intervention: The Delta State NMA issued a clarifying statement noting that the facility mentioned in the original report is a recognized institution in their jurisdiction and confirmed that no such diagnosis was issued to Blessing Okoro by the facility in question.
The Fallout and “Miscommunication” Claim
As the evidence of the “fake” results went viral, the reaction from the public and the medical community has been swift:
- VeryDarkMan’s Involvement: Social critic Martins Vincent Otse (VeryDarkMan) was among the first to raise alarms, questioning the authenticity of the fundraising efforts and calling for a full investigation into the “medical fraud.”
- Deactivated Accounts: Following the surge of “refund” demands from donors and threats of legal action from Miss Mbara’s camp, Blessing CEO and her partner reportedly deactivated their social media accounts earlier this week.
- The Pivot: Before deactivating, Blessing attempted to frame the situation as a “miscommunication” or a “social experiment,” a defense that has been widely rejected by critics who view the exploitation of a terminal illness for financial gain as a serious ethical and legal bridge too far.
